Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 610

    1.

    From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

    Wolf G, Chen S, Ziyadeh FN.

    Diabetes. 2005 Jun;54(6):1626-34. Review.PMID: 15919782 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.

    Wolf G, Ziyadeh FN.

    Nephron Physiol. 2007;106(2):p26-31. Epub 2007 Jun 6. Review.PMID: 17570945 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

    Ziyadeh FN, Wolf G.

    Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.PMID: 18220694 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.

    Gruden G, Perin PC, Camussi G.

    Curr Diabetes Rev. 2005 Feb;1(1):27-40. Review.PMID: 18220580 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

    Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.

    Kidney Int. 2002 Sep;62(3):901-13.PMID: 12164872 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Podocyte biology in diabetic nephropathy.

    Li JJ, Kwak SJ, Jung DS, Kim JJ, Yoo TH, Ryu DR, Han SH, Choi HY, Lee JE, Moon SJ, Kim DK, Han DS, Kang SW.

    Kidney Int Suppl. 2007 Aug;(106):S36-42. Review.PMID: 17653209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.

    Okada M, Takemura T, Yanagida H, Yoshioka K.

    Kidney Int. 2002 Jan;61(1):113-24.PMID: 11786091 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The podocyte: a potential therapeutic target in diabetic nephropathy?

    Marshall SM.

    Curr Pharm Des. 2007;13(26):2713-20. Review.PMID: 17897015 [PubMed - indexed for MEDLINE]Related articles

    9.

    Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

    Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

    Kidney Int. 2005 Oct;68(4):1554-61.PMID: 16164632 [PubMed - indexed for MEDLINE]Related articles

    10.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    11.

    Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.

    Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M.

    Lab Invest. 2002 Jan;82(1):25-35.PMID: 11796823 [PubMed - indexed for MEDLINE]Related articles

    12.

    The podocyte: a major player in the development of diabetic nephropathy?

    Marshall SM.

    Horm Metab Res. 2005 Apr;37 Suppl 1:9-16. Review.PMID: 15918105 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

    Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

    Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. Epub 2009 Feb 11.PMID: 19211686 [PubMed - indexed for MEDLINE]Related articles

    14.

    Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.

    Ziyadeh FN.

    Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S38-41. Epub 2008 Oct 7. Review.PMID: 18842317 [PubMed - indexed for MEDLINE]Related articles

    15.

    The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?

    Reddy GR, Kotlyarevska K, Ransom RF, Menon RK.

    Curr Opin Nephrol Hypertens. 2008 Jan;17(1):32-6. Review.PMID: 18090667 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

    Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.

    Am J Physiol Renal Physiol. 2007 Nov;293(5):F1657-65. Epub 2007 Sep 5.PMID: 17804483 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.

    Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M.

    Diabetes. 2007 Aug;56(8):2155-60. Epub 2007 May 29.PMID: 17536064 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.

    Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Zaoui P, Pinel N, Cordonnier DJ, Gilbert RE.

    Diabetologia. 2002 Nov;45(11):1572-6. Epub 2002 Sep 25.PMID: 12436341 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data